Melinda Wenner

Articles by Melinda Wenner

The Scientist Placeholder Image

Seeing Schizophrenia

The Scientist Placeholder Image

Supplement: Molecular Mysteries

The Scientist Placeholder Image

Supplement: Gazing Downstream

The Scientist Placeholder Image

Supplement: Seeing Schizophrenia

The Scientist Placeholder Image

Supplement: Neurotrailblazer

The Scientist Placeholder Image

Autism, as seen onstage

The Scientist Placeholder Image

Portraits of scientists, on display

The Scientist Placeholder Image

Humans and monkeys, center stage

The Scientist Placeholder Image

A war against war metaphors

The Scientist Placeholder Image

Why vaccines are a good investment

The Scientist Placeholder Image

The Amygdaloids: Scientists who rock out

The Scientist Placeholder Image

Designing a disease -- and its drug

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies